65% of MS patients discontinue this therapy within a yearPublished: 23 January 2022 Baclofen is one of the drugs licenced to treat spasticity in people with multiple sclerosis (MS), but a new Swedish population-based study showed half of patients discontinued it in the first six months, and 90% stopped within

UK study finds no protective benefits of alcohol against MSPublished: 04 January 2022 Drinking alcohol doesn’t have any effect on the likeliness of developing multiple sclerosis (MS), according to a new large-scale analysis. Some previous studies have suggested that alcohol consumption may be linked with a lower risk of MS,

Intestinal inflammation markers found in MS patientsPublished: 20 December 2022 A new study has found that people with multiple sclerosis (MS) have higher levels of a protein called lipocalin 2 (Lcn-2) in their stool, which is a marker for inflammation in the intestine, compared with healthy people without MS. The